Konrad E Bloch Selected Research

Emphysema

12/2014	Long-term effect of vasodilator therapy in pulmonary hypertension due to COPD: a retrospective analysis.
5/2009	Lung volume reduction surgery in nonheterogeneous emphysema.
1/2009	Persistent benefit from lung volume reduction surgery in patients with homogeneous emphysema.
7/2006	Lung-volume reduction surgery as an alternative or bridging procedure to lung transplantation.
11/2004	Model-based versus clinical prediction of the spirometric response to lung volume reduction surgery.
9/2004	Long-term results after lung volume reduction surgery in patients with alpha1-antitrypsin deficiency.
8/2002	Successful lung volume reduction surgery in a child with severe airflow obstruction and hyperinflation due to constrictive bronchiolitis.
5/2002	Gain and subsequent loss of lung function after lung volume reduction surgery in cases of severe emphysema with different morphologic patterns.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Konrad E Bloch Research Topics

Disease

26	Chronic Obstructive Pulmonary Disease (COPD) 04/2024 - 12/2014
21	Pulmonary Hypertension 01/2024 - 01/2006
17	Hypoxia (Hypoxemia) 01/2022 - 02/2009
13	Sleep Apnea Syndromes (Sleep Apnea) 01/2023 - 12/2003
9	Obstructive Sleep Apnea 01/2021 - 12/2003
8	Altitude Sickness (Mountain Sickness) 01/2023 - 01/2006
8	Emphysema 12/2014 - 05/2002
7	Dyspnea (Shortness of Breath) 01/2021 - 05/2002
6	Hyperoxia 03/2023 - 01/2017
6	Apnea 01/2021 - 12/2008
6	Sleepiness 01/2020 - 03/2007
5	Heart Failure 09/2023 - 01/2012
4	Pulmonary Edema 01/2011 - 10/2006
3	Asthma (Bronchial Asthma) 01/2022 - 07/2019
3	Inflammation (Inflammations) 01/2021 - 11/2011
3	Respiratory Insufficiency (Respiratory Failure) 01/2019 - 01/2005
3	Central Sleep Apnea (Central Sleep Apnea Syndrome) 01/2019 - 01/2011
3	Insulin Resistance 01/2013 - 03/2007
2	Vascular Diseases (Vascular Disease) 01/2024 - 03/2023
2	Congenital Heart Defects (Congenital Heart Defect) 03/2023 - 02/2022
2	Hyperventilation 01/2023 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2010
2	Pulmonary Emphysema 08/2018 - 01/2009
2	Nasal Obstruction 02/2009 - 02/2005
1	COVID-19 04/2024
1	Respiratory Hypersensitivity 01/2022
1	Pulmonary Arterial Hypertension 10/2021
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Hyperglycemia 01/2019
1	Fibrosis (Cirrhosis) 08/2018
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2018
1	Brain Hypoxia (Cerebral Hypoxia) 01/2018
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Disease Progression 01/2017
1	Lung Diseases (Lung Disease) 01/2016
1	Gastroparesis 01/2016
1	Constipation 01/2014
1	Acidosis 01/2014
1	Polycythemia (Erythrocytosis) 04/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2013
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 09/2012
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2012
1	Hemorrhage 02/2011
1	Retinal Hemorrhage 02/2011
1	Brain Edema (Cerebral Edema) 05/2008

Drug/Important Bio-Agent (IBA)

41	Oxygen (Dioxygen)IBA 12/2023 - 01/2005
17	Acetazolamide (Diamox)FDA LinkGeneric 01/2024 - 01/2011
12	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2006
6	GoldIBA 01/2023 - 01/2018
5	Carbon DioxideIBA 03/2023 - 09/2005
4	AT 760IBA 04/2024 - 01/2019
3	prednylidene (Pred)IBA 03/2023 - 01/2020
3	Vasodilator Agents (Vasodilators)IBA 01/2022 - 12/2014
3	GasesIBA 01/2021 - 01/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 08/2009
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2017
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2020 - 10/2006
2	Hemoglobins (Hemoglobin)IBA 08/2014 - 04/2013
2	LipidsIBA 01/2013 - 11/2011
2	Retinaldehyde (Retinal)IBA 02/2011 - 02/2009
2	Tadalafil (Cialis)FDA Link 08/2009 - 10/2006
1	AntigensIBA 04/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Immunoglobulin E (IgE)IBA 08/2020
1	3,5-diisopropylsalicylic acid (DIPS)IBA 01/2020
1	M 92 (VA 2)IBA 01/2019
1	TabletsIBA 01/2019
1	NitrogenIBA 11/2018
1	Opioid Analgesics (Opioids)IBA 01/2017
1	goblet cell silencer inhibitorIBA 01/2016
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2016
1	Iloprost (Ventavis)FDA Link 12/2014
1	ProstaglandinsIBA 12/2014
1	Endothelin Receptor AntagonistsIBA 12/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014
1	CytokinesIBA 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2013
1	C-Reactive ProteinIBA 01/2013
1	oxidized low density lipoproteinIBA 01/2013
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2013
1	Troponin T (Troponin T1)IBA 01/2013
1	CatecholaminesIBA 11/2011
1	APTIBA 11/2010
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 08/2009
1	xylometazoline (stas)IBA 12/2008
1	Indicators and Reagents (Reagents)IBA 05/2008

Therapy/Procedure

31	Therapeutics 12/2023 - 08/2002
9	Continuous Positive Airway Pressure 01/2021 - 12/2003
8	Pneumonectomy (Lung Volume Reduction) 08/2018 - 05/2002
3	Lung Transplantation 05/2009 - 08/2002
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2017 - 01/2014
1	Drug Therapy (Chemotherapy) 09/2023
1	Intravenous Administration 01/2021
1	Breathing Exercises 07/2019
1	Cannula 01/2019
1	Artificial Respiration (Mechanical Ventilation) 01/2019
1	Noninvasive Ventilation 01/2019
1	Decompression 08/2018
1	Aftercare (After-Treatment) 01/2018